carbidopa has been researched along with Ventricular Fibrillation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lown, B; Rabinowitz, SH | 1 |
| Lehnert, H; Lombardi, F; Lorenzo, AV; Lown, B; Raeder, EA; Verrier, RL; Wurtman, RJ | 1 |
2 other study(ies) available for carbidopa and Ventricular Fibrillation
| Article | Year |
|---|---|
Central neurochemical factors related to serotonin metabolism and cardiac ventricular vulnerability for repetitive electrical activity.
Topics: 5-Hydroxytryptophan; Animals; Blood Pressure; Carbidopa; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Dogs; Female; Heart Rate; Heart Ventricles; Male; Phenelzine; Serotonin; Sympathetic Nervous System; Tryptophan; Ventricular Fibrillation | 1978 |
Increased release of brain serotonin reduces vulnerability to ventricular fibrillation in the cat.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Animals; Blood Pressure; Carbidopa; Cats; Coronary Disease; Female; Heart; Heart Rate; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Phenelzine; Serotonin; Ventricular Fibrillation | 1987 |